DK2343314T3 - Kalciumfluoridfosfopeptidforbindelser - Google Patents

Kalciumfluoridfosfopeptidforbindelser

Info

Publication number
DK2343314T3
DK2343314T3 DK10184405.8T DK10184405T DK2343314T3 DK 2343314 T3 DK2343314 T3 DK 2343314T3 DK 10184405 T DK10184405 T DK 10184405T DK 2343314 T3 DK2343314 T3 DK 2343314T3
Authority
DK
Denmark
Prior art keywords
calcium fluoride
phosphopeptide
compounds
phosphopeptide compounds
fluoride
Prior art date
Application number
DK10184405.8T
Other languages
English (en)
Inventor
Eric C Reynolds
Original Assignee
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Melbourne filed Critical Univ Melbourne
Application granted granted Critical
Publication of DK2343314T3 publication Critical patent/DK2343314T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK10184405.8T 1997-03-13 1998-03-13 Kalciumfluoridfosfopeptidforbindelser DK2343314T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPO5662A AUPO566297A0 (en) 1997-03-13 1997-03-13 Calcium phosphopeptide complexes
EP98907752.4A EP0968228B1 (en) 1997-03-13 1998-03-13 Calcium phosphopeptide complexes

Publications (1)

Publication Number Publication Date
DK2343314T3 true DK2343314T3 (da) 2014-01-20

Family

ID=3799965

Family Applications (2)

Application Number Title Priority Date Filing Date
DK98907752.4T DK0968228T3 (da) 1997-03-13 1998-03-13 Kalciumfosfopeptidkomplekser
DK10184405.8T DK2343314T3 (da) 1997-03-13 1998-03-13 Kalciumfluoridfosfopeptidforbindelser

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK98907752.4T DK0968228T3 (da) 1997-03-13 1998-03-13 Kalciumfosfopeptidkomplekser

Country Status (11)

Country Link
US (2) US6780844B1 (da)
EP (2) EP0968228B1 (da)
JP (2) JP4541455B2 (da)
AU (1) AUPO566297A0 (da)
CA (2) CA2727634C (da)
DK (2) DK0968228T3 (da)
ES (2) ES2441610T3 (da)
NO (1) NO324623B1 (da)
NZ (1) NZ337801A (da)
PT (2) PT968228E (da)
WO (1) WO1998040406A1 (da)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO566297A0 (en) * 1997-03-13 1997-04-10 University Of Melbourne, The Calcium phosphopeptide complexes
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
US6846500B1 (en) * 1999-03-25 2005-01-25 Cadbury Adams Usa Llc Oral care chewing gums and method of use
CA2359647C (en) * 1999-03-25 2003-12-30 Warner-Lambert Company Oral care chewing gums and confections
GB9929919D0 (en) 1999-12-17 2000-02-09 Hannah Research Inst The Calcium phosphate nanoclusters and their applications
AUPR517701A0 (en) * 2001-05-21 2001-06-14 University Of Melbourne, The Dental restorative materials
MXPA04006542A (es) 2002-01-03 2004-10-04 Procter & Gamble Composiciones bucales estables que contienen complejos de fosfopeptido de caseina y fluooruro.
EP1461005A2 (en) * 2002-01-03 2004-09-29 The Procter & Gamble Company Stable oral compositions comprising casein phosphopeptide complexes and fluoride
AU2003221582A1 (en) 2002-05-03 2003-11-17 Millenium Biologix Inc. Connective tissue stimulating peptides
US7982008B2 (en) * 2002-11-27 2011-07-19 David Bar-Or Treatment of diseases and conditions mediated by increased phosphorylation
JP2005145952A (ja) * 2003-10-23 2005-06-09 Gc Corp う蝕予防用組成物
US20050089481A1 (en) * 2003-10-23 2005-04-28 Gc Corporation Composition for caries prevention
KR20070026372A (ko) * 2003-12-19 2007-03-08 더 유니버시티 오브 멜버른 항미생물 조성물
CN101098673B (zh) * 2004-11-16 2012-02-29 3M创新有限公司 包括磷酸盐的牙科填料和组合物
AU2005306857A1 (en) 2004-11-16 2006-05-26 3M Innovative Properties Company Dental compositions with calcium phosphorus releasing glass
AU2005306869B2 (en) 2004-11-16 2011-11-10 3M Innovative Properties Company Dental fillers including a phosphorus­containing surface treatment
CA2587278A1 (en) * 2004-11-16 2006-05-26 3M Innovative Properties Company Dental fillers, methods, compositions including a caseinate
WO2006056013A1 (en) 2004-11-25 2006-06-01 The University Of Melbourne Stabilized calcium phosphate complexes
JP2006213668A (ja) * 2005-02-04 2006-08-17 Kagoshima Univ 再石灰化促進剤
AU2012200889B2 (en) * 2005-05-02 2014-05-15 Mileutis Ltd. Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
ZA200710374B (en) * 2005-05-02 2009-06-24 Mileutis Ltd Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
UY29515A1 (es) * 2005-05-02 2007-11-30 Mileutis Ltd Composiciones farmaceuticas que constan de peptidos derivados de la caseina y métodos del uso de los mismos
CA2611077C (en) * 2005-06-07 2014-07-15 The University Of Melbourne Dental mineralization
US20060280694A1 (en) * 2005-06-09 2006-12-14 John Peldyak Composition for the mineralization of dental hard tissues and the reduction of caries-inducive microflora
PL1901702T3 (pl) * 2005-06-24 2015-07-31 Univ Melbourne Kompleksy jonowe
AU2006294578B2 (en) 2005-09-28 2013-02-07 The Regents Of The University Of California Calcium binding peptides
US8956594B2 (en) * 2005-10-27 2015-02-17 Ada Foundation Fluoride-calcium compositions, dental products, and methods for providing dental fluoride
CN102358746A (zh) * 2005-12-16 2012-02-22 戴维·坎纳尔 表面活性钙磷酸盐
US10130561B2 (en) 2006-01-31 2018-11-20 Robert L. Karlinsey Functionalized calcium phosphate hybrid systems for confectionery and foodstuff applications
AU2007214265B2 (en) 2006-02-09 2012-06-14 The University Of Melbourne Fluoride composition and methods for dental mineralization
US20070237729A1 (en) * 2006-04-05 2007-10-11 Cadbury Adams Usa, Llc. Impact of calcium phosphate complex on dental caries
AU2011202746B2 (en) * 2006-04-05 2011-10-13 Intercontinental Great Brands Llc Calcium phosphate complex and salts in oral delivery systems
JP2009532065A (ja) * 2006-04-05 2009-09-10 キャドバリー アダムス ユーエスエー エルエルシー 酸含有チューインガム中のリン酸カルシウム錯体
CA2648460C (en) * 2006-04-05 2014-09-23 Cadbury Adams Usa Llc Calcium phosphate complex and salts in oral delivery systems
ZA200808673B (en) * 2006-04-11 2009-12-30 Mileutis Ltd Livestock management for improved reproductive efficiency
US9205036B2 (en) 2007-01-31 2015-12-08 Robert Karlinsey Dental composition
EP2120842B1 (en) * 2007-02-06 2019-08-21 Indiana Nanotech Division of Therametric Technologies, INC. Hybrid organic/inorganic chemical hybrid systems, including functionalized calcium phosphate hybrid systems, and a solid-state method of producing the same
US20080241256A1 (en) * 2007-03-30 2008-10-02 Liisa Kuhn Targeted active agent delivery system based on calcium phosphate nanoparticles
JP4584293B2 (ja) 2007-08-31 2010-11-17 富士通株式会社 窒化物半導体装置、ドハティ増幅器、ドレイン電圧制御増幅器
JP2010047494A (ja) * 2008-08-20 2010-03-04 Gc Corp 歯牙塗布用組成物
JP2010105916A (ja) * 2008-10-28 2010-05-13 Meiji Milk Prod Co Ltd プロセスチーズ類及び齲蝕予防方法
WO2010068359A1 (en) 2008-12-11 2010-06-17 3M Innovative Properties Company Surface-treated calcium phosphate particles suitable for oral care and dental compositions
CN102438580B (zh) * 2009-02-06 2015-06-17 加利福尼亚大学董事会 钙结合剂诱导毛发生长和/或甲生长
JP4850267B2 (ja) * 2009-03-27 2012-01-11 株式会社明治 カゼインホスホペプチド（ｃｐｐ）の免疫学的測定法
RU2423119C2 (ru) * 2009-07-10 2011-07-10 Феликс Аркадьевич Ерусалимов Лечебно-профилактическое средство для эмали зуба
US8632754B2 (en) 2009-08-03 2014-01-21 Mcneil-Ppc, Inc. Tooth sensitivity treatment compositions
US8603442B2 (en) 2009-08-03 2013-12-10 Mcneil-Ppc, Inc. Tooth sensitivity treatment compositions
US9060947B2 (en) 2009-08-03 2015-06-23 Mcneil-Ppc, Inc. Tooth sensitivity treatment compositions
JP2011073983A (ja) 2009-09-29 2011-04-14 Gc Corp 歯牙塗布用組成物
JP2011162470A (ja) 2010-02-09 2011-08-25 Gc Corp 歯牙用被覆材
ES2593456T3 (es) * 2010-08-24 2016-12-09 Safewhite, Inc. Métodos y materiales para proporcionar un aspecto blanco a los dientes
JP2013163656A (ja) * 2012-02-10 2013-08-22 Gc Corp 歯磨剤
GB201212222D0 (en) * 2012-07-10 2012-08-22 Univ Dundee Improved apparatus and method for mineralising biological materials
PL3024428T3 (pl) 2013-07-23 2021-07-05 The University Of Melbourne Kompozycje i sposoby mineralizacji zębów
DE102013109846A1 (de) 2013-09-09 2015-03-12 Heraeus Kulzer Gmbh Formulierungen und Kit zur biomimetischen Abscheidung von Apatit auf Zähnen
DE102013109848A1 (de) 2013-09-09 2015-03-12 Heraeus Kulzer Gmbh Applikationssystem zur einfachen, 3-dimensionalen Anwendung von medizinischen, kosmetischen oder Arzneimittel enthaltenden Zahnpflegeprodukten
DE102013109847A1 (de) 2013-09-09 2015-03-12 Heraeus Kulzer Gmbh Formulierungen und Kit zur biomimetischen Abscheidung von Apatit auf Zähnen
EP2853256A1 (en) 2013-09-25 2015-04-01 Credentis AG Dental care product for tooth whitening
ES2669548T3 (es) 2013-09-25 2018-05-28 Credentis Ag Producto de cuidado dental para el blanqueamiento de los dientes
RU2716134C2 (ru) 2013-12-24 2020-03-06 Де Юниверсити Оф Мельбурн Стабилизированные композиции на основе олова (II)
ES2557183B1 (es) 2014-07-21 2016-11-03 Consejo Superior De Investigaciones Científicas (Csic) Procedimiento de obtención de nanopartículas de fosfato de calcio amorfo recubiertas de citrato y dopadas con flúor
JP2016102069A (ja) * 2014-11-27 2016-06-02 株式会社ジーシー 歯面清掃方法、歯面清掃用組成物、及びその使用方法
RU2720242C2 (ru) * 2014-12-24 2020-04-28 Юниверсити Оф Мельбурн Минерализующие фторсодержащие композиции
US10219986B2 (en) 2015-03-04 2019-03-05 Modern Ideas LLC Stabilized calcium phosphate and methods of forming same
US11696879B2 (en) 2016-05-26 2023-07-11 3M Innovative Properties Company Therapeutic dental pastes and related methods and kits
US12109284B2 (en) 2016-11-08 2024-10-08 Dentherapy Ltd Compositions comprising fluoride and calcium and method for preparing them
KR102862249B1 (ko) * 2017-03-14 2025-09-19 더 유니버시티 오브 멜버른 치은염을 위한 치료
EA201991935A1 (ru) 2017-03-14 2020-02-14 Де Юниверсити Оф Мельбурн Комплексы для лечения чувствительности
CA3133097A1 (en) * 2019-03-13 2020-09-17 The University Of Melbourne Compositions and methods for promoting mineralization
JP2022524856A (ja) * 2019-03-13 2022-05-10 ザ ユニバーシティー オブ メルボルン 低石灰化病変の隠蔽
GB202010987D0 (en) 2020-07-16 2020-09-02 Dentherapy Ltd Oral care compositions and methods
US11154470B1 (en) 2020-07-31 2021-10-26 vVardis AG Anti-inflammatory and senolytic dental care product with tooth whitening characteristics
EP3984517A1 (en) 2020-10-19 2022-04-20 Credentis AG Accelerating tooth remineralisation and bone regeneration with self-assembling peptides and amorphous calcium phosphate
GB202110114D0 (en) 2021-07-14 2021-08-25 Dentherapy Ltd Oral care compositions for use in treaatment
EP4486285A4 (en) * 2022-02-28 2026-03-04 Psilox Ab AMORPHE CALCIUM-MAGNESIUM FLUORIDE PHOSPHATE PARTICLES
US20260165919A1 (en) 2022-10-28 2026-06-18 Queen Mary University Of London Toothpaste composition
WO2025008636A1 (en) 2023-07-06 2025-01-09 Dentherapy Ltd Oral care compositions for use in the treatment of dental health conditions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199891A (en) * 1981-03-04 1985-07-31 Univ Melbourne Caries-inhibiting compositions containing casein or x-s-casein or phosuitin
US5130123A (en) 1981-03-04 1992-07-14 The University Of Melbourne Dentifrice
US5015628A (en) 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
CA1315480C (en) 1986-06-12 1993-03-30 Eric Charles Reynolds Phosphopeptides
US5227154A (en) * 1991-08-22 1993-07-13 The University Of Melbourne Phosphopeptides for the treatment of dental calculus
DK0651652T3 (da) * 1992-06-29 2000-07-24 Univ Melbourne Behandling af sensitive tænder
CH684773A5 (fr) * 1992-12-28 1994-12-30 Nestle Sa Composition alimentaire anti-cariogène.
KR0140248B1 (ko) * 1995-03-23 1998-06-15 한상기 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법
PT748591E (pt) * 1995-06-16 2002-04-29 Nestle Sa Caseinas micelares fluoradas
JP2974604B2 (ja) 1996-01-23 1999-11-10 雪印乳業株式会社 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用
US5741773A (en) 1996-04-26 1998-04-21 Colgate Palmolive Company Storage stable dentifrice composition containing an antibacterial casein glycomacropeptide adjuvant
AUPO566297A0 (en) * 1997-03-13 1997-04-10 University Of Melbourne, The Calcium phosphopeptide complexes

Also Published As

Publication number Publication date
ES2434097T3 (es) 2013-12-13
ES2441610T3 (es) 2014-02-05
EP0968228A4 (en) 2004-04-21
JP2009024002A (ja) 2009-02-05
EP2343314A3 (en) 2011-08-24
CA2727634A1 (en) 1998-09-17
AUPO566297A0 (en) 1997-04-10
NO994388L (no) 1999-11-12
HK1159120A1 (en) 2012-07-27
US20050037948A1 (en) 2005-02-17
CA2283680A1 (en) 1998-09-17
PT968228E (pt) 2013-10-30
JP4541455B2 (ja) 2010-09-08
EP0968228B1 (en) 2013-08-21
DK0968228T3 (da) 2013-11-18
WO1998040406A1 (en) 1998-09-17
JP4843000B2 (ja) 2011-12-21
US6780844B1 (en) 2004-08-24
EP0968228A1 (en) 2000-01-05
JP2002500626A (ja) 2002-01-08
NZ337801A (en) 2001-05-25
PT2343314E (pt) 2014-01-14
US7312193B2 (en) 2007-12-25
NO994388D0 (no) 1999-09-10
NO324623B1 (no) 2007-11-26
CA2283680C (en) 2011-05-03
EP2343314B1 (en) 2013-10-09
CA2727634C (en) 2014-05-27
HK1025580A1 (en) 2000-11-17
EP2343314A2 (en) 2011-07-13

Similar Documents

Publication Publication Date Title
DK0968228T3 (da) Kalciumfosfopeptidkomplekser
PT860428E (pt) Compostos pirimidiona
IS5479A (is) Efnasambönd
IS5478A (is) Efnasambönd
IS5477A (is) Efnasambönd
ID22850A (id) Senyawa-senyawa pirazina
ID19609A (id) Senyawa-senyawa heterosiklik
ID19403A (id) Senyawa-senyawa heterosiklik
ID16152A (id) Senyawa-senyawa triaril
NO994877D0 (no) Kalsilytiske forbindelser
EE200000044A (et) Uued ühendid
ID15904A (id) Senyawa-senyawa tiofenopirimidina
BR9710352A (pt) Compostos piridilpirrole
ID20323A (id) Senyawa-senyawa triazinilaminostilbena
DE69716924D1 (de) Phosphonat-nukleotid-verbindungen
NO994900D0 (no) Forbindelser
BR9705635A (pt) Compostos
PT923594E (pt) Compostos de bromotiacumicina
EE9900475A (et) Ühendid
NO996544D0 (no) Forbindelser
DE69709659D1 (de) Halopropargyl-einschlussverbindungen
ID22983A (id) Senyawa-senyawa fluorometoksimino
NO995007D0 (no) Forbindelser
DE69737634D1 (de) Insektizide oxadiazinverbindungen
SE9701397D0 (sv) Compounds